CATALOGO DEI PRODOTTI DELLA RICERCA

DONADELLI, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.925
NA - Nord America 5.218
AS - Asia 3.686
SA - Sud America 537
AF - Africa 72
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.453
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.089
RU - Federazione Russa 2.452
SG - Singapore 1.401
GB - Regno Unito 1.234
CN - Cina 1.211
IT - Italia 613
BR - Brasile 449
HK - Hong Kong 346
DE - Germania 323
VN - Vietnam 317
FR - Francia 298
SE - Svezia 280
IE - Irlanda 238
FI - Finlandia 208
KR - Corea 94
UA - Ucraina 68
CA - Canada 65
ID - Indonesia 63
MX - Messico 51
TR - Turchia 50
NL - Olanda 43
JP - Giappone 40
BE - Belgio 38
IN - India 37
AR - Argentina 36
PL - Polonia 34
ES - Italia 33
BD - Bangladesh 32
AT - Austria 23
IR - Iran 15
ZA - Sudafrica 15
BJ - Benin 14
SA - Arabia Saudita 12
CO - Colombia 11
EC - Ecuador 11
IQ - Iraq 11
TG - Togo 9
AU - Australia 8
LT - Lituania 8
PK - Pakistan 8
VE - Venezuela 8
UZ - Uzbekistan 7
CL - Cile 6
MA - Marocco 6
MY - Malesia 6
IL - Israele 5
PE - Perù 5
PY - Paraguay 5
DZ - Algeria 4
KZ - Kazakistan 4
RO - Romania 4
TN - Tunisia 4
BG - Bulgaria 3
BO - Bolivia 3
CH - Svizzera 3
EG - Egitto 3
GA - Gabon 3
JM - Giamaica 3
JO - Giordania 3
KE - Kenya 3
MM - Myanmar 3
NP - Nepal 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EE - Estonia 2
HN - Honduras 2
KG - Kirghizistan 2
KW - Kuwait 2
ML - Mali 2
NG - Nigeria 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TZ - Tanzania 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
KI - Kiribati 1
LU - Lussemburgo 1
MD - Moldavia 1
MG - Madagascar 1
Totale 15.441
Salva come PNG Salva come JPEG
Città #
Southend 1.082
Moscow 877
Dallas 678
Chandler 676
Singapore 670
Ashburn 399
Jacksonville 361
Hong Kong 345
Woodbridge 328
Ann Arbor 302
Verona 240
Dublin 236
Beijing 235
New York 187
Houston 151
The Dalles 113
Los Angeles 100
Munich 99
Ho Chi Minh City 94
Lawrence 93
Princeton 93
Wilmington 89
Nanjing 75
Jinan 70
Redmond 70
Shenyang 62
Tianjin 56
Phoenix 55
Helsinki 53
Hanoi 51
Columbus 48
Hebei 48
Buffalo 47
Jakarta 46
Dong Ket 45
Redondo Beach 44
São Paulo 41
Milan 38
Changsha 36
Brussels 35
Redwood City 34
Tokyo 34
Seoul 33
Sindelfingen 33
Turku 33
Venice 32
London 31
Zhengzhou 31
Haikou 30
Nanchang 28
Council Bluffs 25
Santa Clara 25
Düsseldorf 24
Guangzhou 23
Montreal 23
Ningbo 23
Seattle 23
Warsaw 23
Boardman 22
Brooklyn 21
Hangzhou 21
Lappeenranta 21
Mexico City 21
Norwalk 21
Jiaxing 20
Frankfurt am Main 19
Boston 18
Rio de Janeiro 18
Kent 17
San Jose 17
Stockholm 17
Toronto 17
Taizhou 16
Chicago 15
Manchester 15
Nuremberg 15
Cotonou 14
Haiphong 14
Poplar 14
San Francisco 14
Augusta 13
Orem 13
Taiyuan 13
Caserta 12
Madrid 12
Atlanta 11
Denver 11
Johannesburg 11
Querétaro 11
Vienna 11
Washington 11
Chennai 10
Fuzhou 10
Auburn Hills 9
Da Nang 9
Falkenstein 9
Falls Church 9
Lomé 9
Bologna 8
Shanghai 8
Totale 9.473
Salva come PNG Salva come JPEG
Nome #
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism 304
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 266
Gemcitabine response in pancreatic adenocarcinoma cells is synergistically enhanced by dithiocarbamate derivatives 260
Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival 237
Cytotoxicity of Polyspermine-Ribonuclease A and Polyspermine-Dimeric Ribonuclease A 214
Autophagy induced by p53-reactivating molecules protects pancreatic cancer cells from apoptosis. 214
ISOLATION AND DRUG SENSITIVITY OF CANCER STEM CELLS OBTAINED FROM PANCREATIC ADENOCARCINOMA CELL LINES 213
Activation of the Interleukin-6 promoter by a dominant negative mutant of c-Jun 209
Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells. 202
Role of mitochondrial uncoupling protein-2 in cancer cell resistance to gemcitabine 199
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 198
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 198
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 197
Intracellular zinc increase inhibits p53(-/-) pancreatic adenocarcinoma cell growth by ROS/AIF-mediated apoptosis 191
UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells 186
Bovine seminal ribonuclease triggers Beclin1-mediated autophagic cell death in pancreatic cancer cells 186
Pancreatic endocrine tumours, a proteomic investigation of the trichostatin-A antitumoral effect 185
Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists 181
Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells 181
REDOX SIGNALING HYPERSENSITIVITY DISTINGUISHES CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH FAVORABLE PROGNOSIS 180
Hyaluronic acid-coated liposomes for active targeting of gemcitabine 179
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition 178
Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem Cells 177
Cell communication and signaling: how to turn bad language into positive one 175
Regulation of miR-23b expression and its dual role on ROS production and tumour development 173
Gain-of-function mutant p53 enhances mitochondrial ROS through the inhibition of PGC-1α/UCP2 axis in cancer cells 173
The rs1001179 SNP and CpG methylation regulate catalase expression in chronic lymphocytic leukemia 169
Proteomics in pancreatic cancer research. 166
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression 164
Low catalase expression confers redox hypersensitivity and identifies an indolent clinical behavior in CLL 164
HUMAN T-LYMPHOBLASTIC LEUKAEMIA CELLS PRODUCE IL-8 IN RESPONSE TOCXCL12 SECRETED BY NORMAL BONE MARROW STROMA 162
Onconase induces autophagy sensitizing pancreatic cancer cells to gemcitabine and activates Akt/mTOR pathway in a ROS-dependent manner 161
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 161
Browsing the oldest antioxidant enzyme: catalase and its multiple regulation in cancer 161
MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines 160
Identification of a candidate alternative promoter region of the human Bcl2L11 (Bim) gene 155
A comparison study on RNase A oligomerization induced by cisplatin, carboplatin and oxaliplatin 155
Double Domain Swapping in Bovine Seminal RNase: Formation of Distinct N- and C-swapped Tetramers and Multimers with Increasing Biological Activities 154
Increase of RNase A N-terminus Polarity or C-terminus Apolarity Changes the Two Domains' Propensity To Swap and Form the Two Dimeric Conformers of the Protein 152
UCP2, a mitochondrial protein regulated at multiple levels 151
Regulation of autophagy by nuclear GAPDH and its aggregates in cancer and neurodegenerative disorders 150
Effects of CD20 antibodies and kinase inhibitors on B-cell receptor signalling and survival of chronic lymphocytic leukaemia cells 149
Mitochondrial uncoupling protein-2 inhibition promotes gemcitabine response in cancer cells. 148
Onconase Dimerization Through 3D Domain Swapping: Structural Investigations and Increase Of The Apoptotic Effect In Cancer Cells 148
Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine 147
Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2-· production in cancer cells 146
Oncometabolites in cancer aggressiveness and tumour repopulation 146
Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine 145
Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2'-deoxycytidine treatment is associated with activation of the interferon signalling pathway 143
The antioxidant uncoupling protein 2 stimulates hnRNPA2/B1, GLUT1 and PKM2 expression and sensitizes pancreas cancer cells to glycolysis inhibition 143
UCP2 inhibition induces ROS/Akt/mTOR axis: role of GAPDH nuclear translocation in genipin/everolimus anticancer synergism 142
Mutant p53 and mTOR/PKM2 regulation in cancer cells 141
Gut microbiota modulates seizure susceptibility 138
The antioxidant mitochondrial protein UCP2 promotes cancer development connecting theWarburg effect and autophagy 137
Extracellular matrix composition modulates the responsiveness of differentiated and stem pancreatic cancer cells to lipophilic derivate of gemcitabine 137
Autocrine mechanisms of cancer chemoresistance 136
The metabolic landscape of cancer stem cells 135
Mutant p53 proteins alter cancer cell secretome and tumour microenvironment: involvement in cancer invasion and metastasis 135
Mutant p53-Associated Molecular Mechanisms of ROS Regulation in Cancer Cells 135
3-Bromo-Isoxazoline Derivatives Inhibit GAPDH Enzyme in PDAC Cells Triggering Autophagy and Apoptotic Cell Death 132
Mutant p53 affects the mitochondrial proteome, promoting mitochondrial fragmentation and OXPHOS in pancreatic ductal adenocarcinoma cells 128
Zinc depletion efficiently inhibits pancreatic cancer cell growth by increasing the ratio of antiproliferative/proliferative genes. 128
Rehabilitation and biomarkers of stroke recovery: study protocol for a randomized controlled trial 127
Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation. 126
ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma 125
Molecular interplay between mutant p53 proteins and autophagy in cancer cells 124
Mutant p53 induces SIRT3/MnSOD axis to moderate ROS production in melanoma cells 122
Bone marrow stromal cells up-regulate interleukin 8 production in human T-lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-κB and JNK/AP-1 pathways 120
Targeting survival signaling pathways in chronic lymphocytic leukemia via anti-CD20 antibodies 120
CAT rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic Leukemia 119
null 119
Tumor Suppressor Role of Wild-Type P53-Dependent Secretome and Its Proteomic Identification in PDAC 117
Redox sensitive cysteine residues as crucial regulators of wild-type and mutant p53 isoforms 115
Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A 114
Proteomic analysis of pancreatic ductal carcinoma cells treated with 5-aza-2'-deoxycytidine 114
Sex differences in neuromuscular and biological determinants of isometric maximal force 111
Prolonged exposure to simulated microgravity promotes stemness impairing morphological, metabolic and migratory profile of pancreatic cancer cells: a comprehensive proteomic, lipidomic and transcriptomic analysis 111
Synergistic effect of trichostatin A and 5-aza-2'-deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: a proteomic study. 110
Sestrins at the Interface of ROS Control and Autophagy Regulation in Health and Disease 110
The mutant p53-driven secretome has oncogenic functions in pancreatic ductal adenocarcinoma cells 110
MRP5 nitration by NO-releasing gemcitabine encapsulated in liposomes confers sensitivity in chemoresistant pancreatic adenocarcinoma cells 110
Mutant p53 prevents GAPDH nuclear translocation in pancreatic cancer cells favoring glycolysis and 2-deoxyglucose sensitivity 110
Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity against pancreatic cancer cells 109
Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity 108
Interplay between ROS and Autophagy in Cancer and Aging: From Molecular Mechanisms to Novel Therapeutic Approaches 105
Trichostatin A alters cytoskeleton and energy metabolism of pancreatic adenocarcinoma cells: an in depth proteomic study 104
Proteomic Signature of PDAC Cells with Mutant p53 104
Sestrins as a therapeutic bridge between ROS and autophagy in cancer 103
“Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A” 99
Mitochondrial uncoupling protein 2 and pancreatic cancer: a new potential target therapy 99
Morphologic Characterization of Pancreatic Ductal Adenocarcinoma following Post-neoadjuvant Pancreatectomy and Clinical value of Intratumor Heterogeneity 95
To metabolomics and beyond: a technological portfolio to investigate cancer metabolism 94
Proteomic analysis of pancreatic endocrine tumor cell lines treated with the histone deacetylase inhibitor trichostatin A. 94
Regulation of succinate dehydrogenase and role of succinate in cancer 94
Roles for microRNA 23b in regulating autophagy and development of pancreatic adenocarcinoma 90
Reprogramming tumor-immune cell interface in solid and hematological malignancies to enhance response to therapy 88
Fatty pancreas disease: an integrated study on frozen tissues shows distinct compartments of inter/intra-lobular, intra-acinar, and intra-islet fat deposition 87
Increased stability of P21(WAF1/CIP1) mRNA is required for ROS/ERK-dependent pancreatic adenocarcinoma cell growth inhibition by pyrrolidine dithiocarbamate 85
Hypoxia dictates metabolic rewiring of tumors: implications for chemoresistance 81
The cancer secretome and secreted biomarkers 79
Totale 14.632
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.971
article - articoli 47.643
book - libri 0
conference - conferenze 4.328
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.942
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021436 0 0 0 0 0 90 33 49 45 10 106 103
2021/2022815 114 200 20 53 21 19 26 52 25 29 71 185
2022/20231.867 121 196 154 364 158 418 23 98 206 61 50 18
2023/2024940 37 56 74 92 116 217 29 78 15 48 132 46
2024/20252.431 112 153 90 398 129 74 113 142 411 159 206 444
2025/20265.793 559 532 672 1.267 2.296 467 0 0 0 0 0 0
Totale 15.637